Analysis reveals spatial disparities in drug stock-outs due to supply chain management in Zimbabwe, highlighting urgent policy needs.
Drug stock-outs are a public health challenge, especially in developing countries. These drug stock- outs are worsened by poor supply chain management, limited financial resources and shortages of experienced health workers. Regardless of the prevalence of drug stock-outs, a few studies examine the spatial disparities in, and factors influencing, these stock-outs. We investigate the spatial disparities in drug stock-outs and factors contributing to this to bridge the existing literature gap. We use the 2018–20 administrative drug stock-out data from Zimbabwe’s Ministry of Health and Child Care. To achieve the objective, thematic maps are used to map out stock-outs while a random effects model examines factors affecting drug stock-outs. The results highlight the existence of regional disparities in drug stock-out and also establish the presence of spatial autocorrelation in drug stock-outs, indicated by hot spots and cold spots. Regions with higher rates of disease prevalence and poor road infrastructure development have a higher prevalence of drug stock-outs than other regions. Notably, drug stock-outs are high for facilities with previous stock-outs and a long time for drug delivery, as well as for clinics and facilities in rural areas. The existence of high drug stock-outs in rural and hard-to-reach areas is a potential threat to the attainment of universal health coverage. Thus, policy should aim to improve the availability of essential drugs through improvements in supply chain management and ensuring drug distribution to the last mile. Strengthening sector-wide coordination between various Ministries could help in reducing the prevalence of drug stock-outs.
No takes yet. Share an insight, caveat, or question.
Chari et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: